Get the Stockscreener App
14.30
5.24%
-0.79
Quidelortho Corp stock is traded at $14.30, with a volume of 917.33K.
It is down -5.24% in the last 24 hours and down -19.03% over the past month.
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.
See More
Previous Close:
$15.09
Open:
$14.86
24h Volume:
917.33K
Relative Volume:
0.54
Market Cap:
$980.63M
Revenue:
$2.66B
Net Income/Loss:
$-1.21B
P/E Ratio:
-0.8025
EPS:
-17.82
Net Cash Flow:
$-159.40M
1W Performance:
+16.40%
1M Performance:
-19.03%
6M Performance:
-39.36%
1Y Performance:
-44.89%
1-Day Range:
$14.11
$15.26
1-Week Range:
$12.07
$15.52
52-Week Range:
$9.92
$35.58
Quidelortho Corp Stock (QDEL) Company Profile
Name
Quidelortho Corp
Sector
Industry
Phone
(858) 552-1100
Address
9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA
Compare QDEL vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
QDEL
Quidelortho Corp
|
14.30 | 1.02B | 2.66B | -1.21B | -159.40M | -17.82 |
ABT
Abbott Laboratories
|
111.25 | 191.92B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
339.21 | 133.18B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
91.27 | 116.18B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
51.83 | 74.52B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
91.60 | 53.63B | 6.30B | 1.07B | 1.09B | 1.8406 |
Quidelortho Corp Stock (QDEL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-07-25 | Downgrade | Citigroup | Buy → Neutral |
| May-08-25 | Upgrade | Jefferies | Hold → Buy |
| Dec-11-24 | Upgrade | Citigroup | Neutral → Buy |
| Dec-10-24 | Initiated | Jefferies | Hold |
| Sep-19-24 | Resumed | UBS | Neutral |
| Sep-05-24 | Upgrade | Craig Hallum | Hold → Buy |
| Mar-04-24 | Downgrade | UBS | Neutral → Sell |
| Feb-14-24 | Downgrade | JP Morgan | Neutral → Underweight |
| Dec-11-23 | Downgrade | Citigroup | Buy → Neutral |
| Dec-12-22 | Upgrade | Citigroup | Neutral → Buy |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Oct-14-22 | Upgrade | UBS | Sell → Neutral |
| Sep-19-22 | Initiated | Citigroup | Neutral |
| Jul-20-22 | Initiated | UBS | Sell |
| Jun-17-22 | Resumed | JP Morgan | Neutral |
| Feb-22-22 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jan-22-21 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-12-20 | Downgrade | JP Morgan | Neutral → Underweight |
| Mar-26-20 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-23-18 | Resumed | Raymond James | Strong Buy |
| Mar-08-18 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jan-22-18 | Reiterated | Barclays | Overweight |
| Jan-04-18 | Upgrade | CL King | Neutral → Buy |
| Sep-19-17 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Jul-18-17 | Upgrade | Canaccord Genuity | Hold → Buy |
| Jul-18-17 | Upgrade | William Blair | Mkt Perform → Outperform |
| Apr-25-17 | Reiterated | Canaccord Genuity | Hold |
| Feb-17-17 | Initiated | CL King | Neutral |
| Dec-16-16 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jun-13-16 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Feb-18-16 | Reiterated | Barclays | Overweight |
| Feb-09-16 | Downgrade | Canaccord Genuity | Buy → Hold |
| Jan-08-16 | Reiterated | Canaccord Genuity | Buy |
| Dec-14-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Sep-02-15 | Initiated | Barclays | Overweight |
| Jul-31-13 | Reiterated | Canaccord Genuity | Buy |
| Mar-03-11 | Downgrade | Wedbush | Outperform → Neutral |
View All
Quidelortho Corp Stock (QDEL) Latest News
QuidelOrtho (NASDAQ:QDEL) Stock Rating Lowered by Zacks Research - MarketBeat
QuidelOrtho (QDEL) Is Down 7.5% After Cutting 2026 Revenue Outlook Amid Softer COVID Testing Demand - simplywall.st
QuidelOrtho (QDEL) Q2 2026 Earnings Call Transcript - AOL.com
Invesco Ltd. (QDEL holder) reports 5.1% beneficial stake in QuidelOrtho Corp - Stock Titan
QuidelOrtho (QDEL) Stock Sees Fair Value Cut As Analysts Rework Growth Expectations - Yahoo Finance
QuidelOrtho Corporation (QDEL) Stock Forecasts - Yahoo Finance
QuidelOrtho Corp (QDEL) Stock Up 6.0% and Still Undervalued -- G - GuruFocus
Neuberger Berman Group LLC Trims QuidelOrtho Corp (QDEL) Stake -- Shares Trade 59% Below GF Value - GuruFocus
Why QuidelOrtho (QDEL) Stock Is Nosediving - Yahoo Finance
QuidelOrtho partially recovers from earnings slide, rising 12% (QDEL:NASDAQ) - Seeking Alpha
QuidelOrtho (NASDAQ:QDEL) Shares Up 8.5%Should You Buy? - MarketBeat
QuidelOrtho Corporation (QDEL) Stock Positioned for Reweighting Towards Peers Amid Deleveraging - Yahoo Finance
QuidelOrtho Corporation revenue up 3% to USD 631M in Q2 2026 - Medical Buyer
QuidelOrtho Corp (QDEL) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com
QuidelOrtho Corp (QL1A.DU) options chain - Yahoo Finance Australia
QuidelOrtho (QDEL) Stock Sinks As Cash Burn And Debt Eclipse Progress - Sahm
Nasdaq Gains Over 300 Points; US Employers Cut 23,000 Jobs In July - Benzinga
QuidelOrtho Corporation 2026 Q2ResultsEarnings Call Presentation (NASDAQ:QDEL) 2026-08-07 - Seeking Alpha
QuidelOrtho (NASDAQ:QDEL) Shares Gap DownTime to Sell? - MarketBeat
QuidelOrtho Corp (QDEL) Stock News Today - tradingkey.com
QuidelOrtho stock drops after Q2 results (QDEL:NASDAQ) - Seeking Alpha
QuidelOrtho Corporation Q2 2026 Earnings Call Summary - Yahoo Finance
QuidelOrtho 2Q Rev $630.9M >QDEL - Moomoo
AUG 06 (REUTERS)QUIDELORTHO Q2 REVENUE USD 630.9 MILLION. - Moomoo
QuidelOrtho Q2 Earnings Call Highlights - MarketBeat
QuidelOrtho Corp Q2 2026: Revenue $630.9M, EPS $(1.36) — 10-Q Summary - TradingView
QuidelOrtho Corp Quarterly Earnings Report - Stock Titan
QuidelOrtho (NASDAQ:QDEL) Issues FY 2026 Earnings Guidance - MarketBeat
Has QuidelOrtho Corp (QDEL) Undervalued Potential After Q2 Earni - GuruFocus
Earnings call transcript: QuidelOrtho beats Q2 2026 estimates but cuts outlook - Investing.com
QuidelOrtho (NASDAQ:QDEL) Posts Earnings Results, Beats Estimates By $0.18 EPS - MarketBeat
QuidelOrtho Corp reports results for the quarter ended June 30Earnings Summary - TradingView
QuidelOrtho (QDEL) Surpasses Q2 Earnings and Revenue Estimates - Yahoo Finance
QuidelOrtho (NASDAQ:QDEL) Surprises With Q2 CY2026 Sales But Stock Drops 21.6% - StockStory
Earnings Flash (QDEL) QuidelOrtho Corporation Posts Q2 Adjusted EPS $0.13 per Share - marketscreener.com
Q2 2026 QuidelOrtho Corp Earnings Call Transcript - GuruFocus
QuidelOrtho: Q2 Earnings Snapshot - marketscreener.com
QuidelOrtho posts Q2 2026 revenue $631M, adjusted EBITDA $129M and revises full-year guidance - TradingView
QuidelOrtho (Nasdaq: QDEL) trims 2026 revenue and EPS guidance - Stock Titan
QuidelOrtho Reports Second Quarter 2026 Financial Results - marketscreener.com
QuidelOrtho Q2 Sales Rose 3% as China Revenue Fell 18.7% - Stock Titan
Sei Investments Co. Buys 57,615 Shares of QuidelOrtho Corporation $QDEL - MarketBeat
QuidelOrtho Corporation Revises Earnings Guidance for the Full Year 2026 - marketscreener.com
Quidelortho Corp (QDEL) News, Articles, Events & Latest Updates - Stocktwits
Neuberger Berman discloses 4.9% QuidelOrtho (QDEL) position in Schedule 13G/A - Stock Titan
QuidelOrtho (QDEL) To Report Earnings Tomorrow: Here Is What To Expect - StockStory
QuidelOrtho (NASDAQ:QDEL) Shares Down 5.7%What's Next? - MarketBeat
QuidelOrtho Corporation (QDEL) Stock Analysis: 20.46% Potential Upside Amidst Market Volatility - directorstalkinterviews.com
Edgestream Partners L.P. Purchases Shares of 117,888 QuidelOrtho Corporation $QDEL - MarketBeat
QDEL|QuidelOrtho Corp|Price:17.748|Chg%:+0.978 - TradingKey
QuidelOrtho (QDEL) Stock Trades Cheap On Sales But Weak On Cash Flow - Yahoo Finance
Quidelortho Corp Stock (QDEL) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.08%
1.18%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):